Echinomycin

Echinomycin
Names
	Other names Quinomycin A; Levomycin
Identifiers
CAS Number	512-64-1 ;
3D model (JSmol)	Interactive image;
ECHA InfoCard	100.164.832
PubChem CID	3197;
CompTox Dashboard (EPA)	DTXSID5031266 ;
	SMILES CC1C(=O)N(C2CSC(C(C(=O)N(C(C(=O)OCC(C(=O)N1)NC(=O)C3=NC4=CC=CC=C4N=C3)C(C)C)C)N(C(=O)C(NC(=O)C(COC(=O)C(N(C2=O)C)C(C)C)NC(=O)C5=NC6=CC=CC=C6N=C5)C)C)SC)C;
Properties
Chemical formula	C51H64N12O12S2
Molar mass	1101.26 g/mol
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

Echinomycin is a peptide antibiotic. It intercalates into DNA at two specific sites, thereby blocking the binding of hypoxia inducible factor 1 alpha (HIF1alpha).

Biosynthesis

Echinomycin is a bis-intercalator peptide and is biosynthesized by a unique nonribosomal peptide synthetase (NRPs).^[1] Echinomycin is isolated from various bacteria such as, Streptomyces lasalienis. It belongs to a family of quinoxaline antibiotics. There is great interest in this group of compounds because they have very potent antibacterial, anticancer, and antiviral activities.^[2]

The biosynthesis of Echinomycin starts with molecule QC. L-tryptophan is the precursor for QC and its biosynthesis parallels the first stage of nikkomycin biosynthesis. After QC is biosynthesized, the adenylation domain-containing Ecm1 activates and transfers QC to FabC using the fatty acid biosynthesis acyl carrier protein (ACP). The first module, Ecm6 accepts the QC-SFabC as the starter unit. Emc7 contains a terminal thioesterase domain which allows the peptide to dimerize and then release. This cyclized product then goes on to Ecm17, an oxioreductase, creating a disulfide bond. The last step in this biosynthesis transforms the disulfide bond into a thioacetal bridge. This transformation takes place with Ecm18, which is quite similar to S-adenosyl-L-methionine (SAM)-dependent methyltransferase.^[2]

References

^ Watanabe, K; Oguri, H; Oikawa, H (April 2009). "Diversification of echinomycin molecular structure by way of chemoenzymatic synthesis and heterologous expression of the engineered echinomycin biosynthetic pathway". Current Opinion in Chemical Biology. 13 (2): 189–96. doi:10.1016/j.cbpa.2009.02.012. PMID 19278894.
^ ^a ^b Watanabe, K; et al. (August 2006). "Total biosynthesis of antitumor nonribosomal peptides in Escherichia coli". Nature chemical biology. 2 (8): 423–8. doi:10.1038/nchembio803. PMID 16799553. {{cite journal}}: Explicit use of et al. in: |first= (help)

This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it.

[Watanabe-1] Watanabe, K; Oguri, H; Oikawa, H (April 2009). "Diversification of echinomycin molecular structure by way of chemoenzymatic synthesis and heterologous expression of the engineered echinomycin biosynthetic pathway". Current Opinion in Chemical Biology. 13 (2): 189–96. doi:10.1016/j.cbpa.2009.02.012. PMID 19278894.

[Watanabe2-2] Watanabe, K; et al. (August 2006). "Total biosynthesis of antitumor nonribosomal peptides in Escherichia coli". Nature chemical biology. 2 (8): 423–8. doi:10.1038/nchembio803. PMID 16799553. {{cite journal}}: Explicit use of et al. in: |first= (help)

[1]

[2]